Free Shipping on orders over $400
The PDI Prevantics Device Swab is the first and only 3.15% (w/v) Chlorhexidine gluconate (CHG) and 70% (v/v) Isopropyl alcohol (IPA) solution to receive 510k clearance from the US Food and Drug Administration (FDA) for use in disinfecting needleless access sites prior to use.
The PDI Prevantics Device Swab helps target one of the 5 primary sources of CRBSI’s. By implementing protocols for the disinfection of needleless access sites, your facility can help reduce the risk of contamination and improve outcomes.
Compliant with evidence-based recommendations from the following organizations:
*The manufacturer has detailed research and other materials to support this product claim. Contact the manufacturer for more product specifics and research documentation.